The world's political record
Records whose title is actually about this topic. Use a country filter if the list is still too broad.
901 records in US in 2022
United States · United States Congress · 28 February 2022
Sets forth the rule for consideration of the bill (H.R. 3967) to improve health care and benefits for veterans exposed to toxic substances.
United States · United States Congress · 28 February 2022
This resolution expresses support for the designation of National Triple-Negative Breast Cancer Day. Triple-negative breast cancer is a distinct form of cancer that does not have the hormone and protein receptors commonly found in breast cancer. As a result, triple-negative breast cancer does not respond to hormone therapy or medicines that target those receptors.
United States · United States Congress · 28 February 2022
This resolution supports the designation of Rare Disease Day and recognizes the importance of decreasing rare diseases, especially among people of color.
United States · United States Congress · 28 February 2022
Right Drug Dose Now Act This bill sets out requirements and activities to address adverse drug events, including using pharmacogenomic testing to prevent them. (Pharmacogenomic testing uses a patient's genetic information to help determine the safety, efficacy, and dosage of medications for treatments.) Specifically, the Department of Health and Human Services (HHS) must report to Congress about the implementation of a national plan to prevent adverse drug events. Additionally, HHS must coordinate with relevant federal agencies on the report and convene a steering committee to update the plan. HHS must also (1) require, as a condition of certification, that health information technologies automatically indicate when pharmacogenomic testing is appropriate before a medication order is completed; and (2) assess electronic health records to identify improvements necessary for developing the capacity for collecting real-world evidence in pharmacogenomics. Furthermore, HHS must consult with the Food and Drug Administration (FDA) to carry out a program to improve reporting of adverse drug events and their association with a patient's genetic status. In addition, the FDA must issue regulations and make other administrative changes to update adverse drug event reporting processes, including to facilitate the acceptance of information directly from electronic health records. The bill also requires the National Human Genomics Research Institute, which is part of the National Institutes of Health, to (1) carry out a public awareness campaign on adverse drug events, and (2) establish a program to educate health care providers and related professionals about pharmacogenomic testing and associated issues.
United States · United States Congress · 28 February 2022
This resolution expresses support for the designation of Rare Disease Day.
United States · United States Congress · 28 February 2022
This resolution recognizes the 100th anniversary of the American College of Surgeons Committee on Trauma. The committee supports injury prevention programs to ensure optimal patient outcomes across the continuum of care.
United States · United States Congress · 25 February 2022
Recall Unsafe Drugs Act of 2022 This bill authorizes the Food and Drug Administration (FDA) to order the recall of certain adulterated or misbranded drugs and contains other related provisions. A producer of a medication must notify the FDA of the identity and location of a drug if the producer has reason to believe that (1) the drug is adulterated or misbranded, and (2) there is a reasonable probability that the drug will cause a threat of serious adverse health consequences or death to humans or animals. If use of a drug may cause serious adverse health consequences or death, the FDA may order the producer to immediately cease distribution and notify affected individuals. After issuing such an order, the FDA may also order a recall after affording the producer an opportunity for an informal hearing. If a drug presents an imminent threat of serious adverse health consequences or death, the FDA may order the producer to immediately recall the drug and notify affected individuals. The distributor may appeal such an order. An individual or entity required to register as a producer of drugs or medical devices must have a recall plan in effect.
United States · United States Congress · 25 February 2022
This resolution supports efforts to improve women's cardiovascular health.
United States · United States Congress · 25 February 2022
No Pro-Abortion Task Force Act This bill prohibits federal funding of the Reproductive Healthcare Access Task Force. The Department of Health and Human Services launched the task force on January 21, 2022, to identify and coordinate departmental activities related to accessing sexual and reproductive health care.
United States · United States Congress · 25 February 2022
No Surprises for COVID-19 Tests Act This bill extends the temporary period during which private health insurance plans must cover testing and related services for COVID-19 without cost sharing. It also temporarily applies certain consumer protections against surprise billing to such testing and related services. Finally, beginning on May 1, 2022, insurance plans without a negotiated price for COVID-19 testing services are no longer required to pay providers the published cash price for such services.
United States · United States Congress · 25 February 2022
Medicare Demonstration of Coverage for Low Vision Devices Act of 2022 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. The bill defines low-vision device to mean a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2022 and each of the next four fiscal years for the CMS to carry out the project.
United States · United States Congress · 25 February 2022
This bill restricts various presidential and federal authorities related to the acquisition of supplies to combat COVID-19. Specifically, the bill prohibits the President from exercising certain authorities under the Defense Production Act of 1950 to prioritize the performance of federal contracts or orders for COVID-19 supplies over the performance of state or territorial contracts or orders. In addition, states or territories may use federal COVID-19 relief funds for COVID-19 supplies that they had been unable to purchase because of prioritized performance of federal contracts or orders. (The Defense Production Act of 1950 confers upon the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods needed for the national defense.) Additionally, the Food and Drug Administration may not ration, limit, restrict access to, or otherwise control the quantity of a medical product authorized for use during an emergency, including by requiring products to be distributed through a state- or territorial-based system.
United States · United States Congress · 22 February 2022
Federal Bureau of Prisons Medical Care Act of 2022 This bill limits the circumstances under which the Bureau of Prisons may assess a fee for health care services provided to a prisoner.
United States · United States Congress · 22 February 2022
This bill requires the National Institutes of Health to study and report on the neurological impacts of COVID-19 on individuals with a neurological disease.
United States · United States Congress · 22 February 2022
National Public Health Act This bill requires the Department of Health and Human Services (HHS) to take a series of actions relating to the impact of certain products on public health. Specifically, HHS must (1) contract with the National Academy of Medicine, or a similar entity, to develop a list of public health crises; (2) develop a list of products that have a specified fiscal impact on the national public health system; and (3) require manufacturers of such products to develop and implement a plan to mitigate the effects of the products on public health.
United States · United States Congress · 22 February 2022
This resolution recognizes forensic nurses for their contributions to improve health outcomes for patients experiencing violence.
United States · United States Congress · 18 February 2022
Boxing Therapy for Parkinson's Access Act of 2022 This bill requires the Department of Veterans Affairs (VA) to furnish boxing-based exercise classes to veterans who (1) are enrolled in the VA health care system, (2) have been diagnosed with Parkinson's disease (or a similar movement disorder), and (3) elect to participate in such classes to treat the disease or disorder.
United States · United States Congress · 18 February 2022
Autism Family Caregivers Act of 2022 This bill establishes a pilot program to provide training for caregivers on improving health and other outcomes for children with autism spectrum disorder and other developmental disabilities or delays. To carry out the program, the Health Resources and Services Administration (HRSA) must award grants to, among other eligible entities, health systems and nonprofits to provide the training. HRSA must also establish a national center to provide technical assistance to grant recipients and to evaluate the program.
United States · United States Congress · 18 February 2022
Program of All-Inclusive Care for the Elderly Plus Act or the PACE Plus Act This bill modifies requirements and establishes programs regarding Programs of All-Inclusive Care for the Elderly (PACE). PACE is a program under Medicare and Medicaid that provides in-home and community services for certain individuals as an alternative to nursing home care. The bill allows Medicare beneficiaries to enroll in a PACE program at any time and provides states with the option to allow Medicaid beneficiaries to do the same. Entities may also apply to become PACE providers at any time, upon specified assurances relating to staffing and other requirements. States that provide Medicaid coverage of long-term care may also choose to expand PACE eligibility for Medicaid beneficiaries who are unable to perform at least two activities of daily living and who meet other specified criteria. Additionally, the bill establishes and provides funds for grant programs for (1) public or nonprofit PACE providers in rural or underserved urban areas for planning, administrative, capital, and other expenses that are necessary for site development; and (2) states that do not have PACE providers for expenses deemed necessary for program establishment. The bill also allows the Center for Medicare and Medicaid Innovation to test a model for expanded PACE eligibility that targets high-need and high-cost populations.
United States · United States Congress · 18 February 2022
Insulin Savings for Patients Act This bill requires 100% of negotiated price concessions for covered insulin products under the Medicare prescription drug benefit to be reflected at the point of sale by 2024. The Government Accountability Office must annually report on the effects of the bill's implementation, including with respect to insulin prices.
United States · United States Congress · 18 February 2022
This joint resolution nullifies the rule issued by the Centers for Disease Control and Prevention on February 3, 2021, that requires the use of face masks on planes, trains, buses, and other public conveyances and at transportation hubs to prevent the transmission of COVID-19.
United States · United States Congress · 18 February 2022
Health Care Worker and First Responder Social Security Beneficiary Choice Act of 2022 This bill excludes wages from employment in the health care workforce or as a first responder during public health emergencies, including the COVID-19 emergency, from income limits that apply to Social Security retirement benefits.
United States · United States Congress · 17 February 2022
This resolution expresses the sense of the Senate that investments in mental health care and substance use disorder care are necessary to address the high prevalence of those suffering from behavioral health conditions.
United States · United States Congress · 17 February 2022
Improving Access to Tele-Behavioral Health Services Act This bill requires the Substance Abuse and Mental Health Services Administration to award grants for community-based mental health services, substance-use disorder services, and peer support services, with a particular focus on services provided virtually. Eligible grantees include health departments, law enforcement or first responder agencies, behavioral health programs, nonprofits, and institutions of higher education.
United States · United States Congress · 17 February 2022
This resolution designates February 28, 2022, as Rare Disease Day.
United States · United States Congress · 17 February 2022
Advancing Student Services In Schools Today Act or the ASSIST Act This bill requires the Department of Health and Human Services to award grants to, among others, local educational agencies to increase the number of mental health and substance use disorder care providers in schools and school-based health centers. It also increases the federal government's share of Medicaid costs for behavioral health services furnished in those settings.
United States · United States Congress · 17 February 2022
Affordable Insulin Now Act This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023. The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill. Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.
United States · United States Congress · 17 February 2022
Behavioral Health Coordination and Communication Act of 2022 This bill establishes, within the Executive Office of the President, the position of Interagency Coordinator for Behavioral Health to coordinate federal programs and activities concerning mental health and substance use disorders. Federal departments and agencies must notify the coordinator when developing or implementing policies related to behavioral health. The Government Accountability Office must report on the role and activities of the coordinator and must study issues related to behavioral health services in school settings and in the juvenile justice system.
United States · United States Congress · 17 February 2022
Commonsense Reporting Act of 2022 This bill addresses the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy under the Patient Protection and Affordable Care Act (PPACA). It requires the Department of the Treasury to develop and implement a reporting system that allows employers to voluntarily report information about their health plans for the current plan year prior to the beginning of open enrollment. The bill also allows electronic transmission of employee and enrollee statements and permits Treasury to accept full names and dates of birth in lieu of dependents' and spouses' Social Security account numbers. The bill also allows certain large employers who do not offer their employees minimum health care coverage 90 days to appeal an assessment for not providing such coverage. The Government Accountability Office must evaluate (1) for the period beginning on January 1, 2015, and ending on December 31, 2020, the notification of employers by PPACA exchanges of the eligibility of employees for advance payments of the premium assistance tax credit or cost-sharing subsidies; and (2) for calendar year 2023, the functionality of the prospective reporting system established by this bill, including the accuracy of information collected.
United States · United States Congress · 17 February 2022
Anna Westin Legacy Act This bill requires the Substance Abuse and Mental Health Services Administration to maintain the National Center of Excellence for Eating Disorders (NCEED). The bill specifies required activities for NCEED, including providing training for frontline health care providers and other professionals.
United States · United States Congress · 17 February 2022
Beneficiary Enrollment Notification and Eligibility Simplification 2.0 Act or the BENES 2.0 Act This bill requires Social Security account statements for individuals attaining ages 60 to 65 to include information about Medicare eligibility, late enrollment penalties, benefit coordination, and related resources. Statements with the required information must be mailed to individuals at least three months before they turn 65; the required information must also be mailed to those who are age 65 or over and are entitled to Social Security benefits three months before their initial Medicare enrollment period begins.
United States · United States Congress · 16 February 2022
Right to Treat Act This bill specifies that no federal agency has the authority to regulate the practice of medicine. It further specifies that no federal law or policy may prohibit or restrict the lawful prescribing of a drug authorized by the Food and Drug Administration.
United States · United States Congress · 16 February 2022
Reducing Hereditary Cancer Act of 2022 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
United States · United States Congress · 16 February 2022
Return Employees to Understaffed Work Sites to Reopen Now Act of 2022 or the RETURN Act of 2022 This bill requires each federal agency to submit to Congress and publish on the agency's website a plan for the agency to resume in-person operations. The plan shall, among other things, include the agency's policy with respect to permitting permanent remote work for employees who can successfully achieve their duties away from their official work sites, metrics to measure the productivity of employees performing remote work to identify employees that fail to fulfill their duties, a plan to provide essential government services in person for individuals in the United States, and measures to prepare for future public health emergencies that can be quickly implemented if remote work becomes necessary. Each agency must submit a report to the General Services Administration recommending termination of the agency's leases of physical work spaces that are underused.
United States · United States House of Representatives · 15 February 2022
United States · United States Congress · 15 February 2022
Preventing Illicit Paraphernalia for Exchange Systems Act or the PIPES Act This bill restricts the use of funding made available through the American Rescue Plan Act of 2021 for community-based overdose prevention programs, syringe services programs, and other harm reduction programs. First, the bill prohibits the use of the act's funding to procure or distribute pipes or other paraphernalia that can be used to smoke, inhale, or ingest narcotics. Second, the bill applies to the act's funding the conditions that apply to other funding from the Department of Health and Human Services for syringe services programs and needle exchange programs. The conditions require that programs (1) operate in a jurisdiction experiencing (or at risk for) increased transmission of hepatitis and HIV infections due to injection drug use, (2) use nonfederal funds for the purchase of syringes or needles, and (3) otherwise follow applicable laws.
United States · United States Congress · 14 February 2022
Preventing Illicit Paraphernalia for Exchange Systems Act or the PIPES Act This bill restricts the use of funding made available through the American Rescue Plan Act of 2021 for community-based overdose prevention programs, syringe services programs, and other harm reduction programs. First, the bill prohibits the use of the act's funding to procure or distribute pipes or other paraphernalia that can be used to smoke, inhale, or ingest narcotics. Second, the bill applies to the act's funding the conditions that apply to other funding from the Department of Health and Human Services for syringe services programs and needle exchange programs. The conditions require that programs (1) operate in a jurisdiction experiencing (or at risk for) increased transmission of hepatitis and HIV infections due to injection drug use, (2) use nonfederal funds for the purchase of syringes or needles, and (3) otherwise follow applicable laws.
United States · United States Congress · 14 February 2022
This joint resolution nullifies a Department of Health and Human Services rule published on November 30, 2021, concerning vaccine and mask requirements to mitigate the spread of COVID-19 in Head Start programs. These programs provide comprehensive early education and development services to low-income children.
United States · United States Congress · 11 February 2022
Halting the Use of Narcotics Through Effective Recovery Act of 2022 or the HUNTER Act of 2022 This bill prohibits the use of federal funds to purchase (or support the purchase of) pipes, syringes, or other paraphernalia that can be used to smoke, inject, or otherwise introduce into the body any controlled substance unlawfully. This includes funds made available through the American Rescue Plan Act of 2021 for overdose prevention, syringe services, and other harm reduction programs.
United States · United States Congress · 11 February 2022
This bill requires the Food and Drug Administration (FDA) to report to Congress on barriers to the domestic manufacturing of imported active pharmaceutical ingredients, finished drug products, and devices that are critical to public health. The report must recommend strategies to overcome such barriers. The FDA may, to the extent appropriate, implement the strategies.
United States · United States Senate · 10 February 2022
United States · United States Congress · 10 February 2022
This joint resolution nullifies the rule issued by the Centers for Disease Control and Prevention on February 3, 2021, that requires the use of face masks on planes, trains, buses, and other public conveyances and at transportation hubs to prevent the transmission of COVID-19.
United States · United States Congress · 10 February 2022
Supporting Care for Dual Eligibles Act This bill establishes and provides funds for grants to support the provision of services to those who are dually eligible for Medicare and Medicaid. Specifically, the bill establishes and provides funds for FY2022 for the Dual Eligible Quality Care Fund. The Centers for Medicare & Medicaid Services (CMS) must use the funds for grants to state Medicaid programs to support quality integrated care for dual eligible beneficiaries, including technology improvements, staff support, and administrative services for beneficiaries. The bill also requires the CMS to biennially audit state Medicaid programs with respect to improper payments; states must also submit plans for mitigating improper payments.
United States · United States Congress · 10 February 2022
Cutting Rampant Access to Crack Kits Act of 2022 or the CRACK Act of 2022 This bill prohibits community-based overdose prevention programs, syringe services programs, and other harm reduction programs from using funds made available through the American Rescue Plan Act of 2021 to procure or distribute pipes or other paraphernalia that can be used to smoke, inhale, or ingest narcotics.
United States · United States Congress · 10 February 2022
Program of All-Inclusive Care for the Elderly Expanded Act or the PACE Expanded Act This bill modifies requirements regarding Programs of All-Inclusive Care for the Elderly (PACE). PACE is a program under Medicare and Medicaid that provides in-home and community services for certain individuals as an alternative to nursing home care. The bill allows Medicare beneficiaries to enroll in a PACE program at any time and provides states with the option to allow Medicaid beneficiaries to do the same. Entities may also apply to become PACE providers at any time, upon specified assurances relating to staffing and other requirements. The bill also (1) allows the Center for Medicare and Medicaid Innovation to test a model for expanded PACE eligibility that targets high-need and high-cost populations, and (2) requires an evaluation of the effectiveness of PACE in rural and underserved areas.
United States · United States Congress · 10 February 2022
Youth Mental Health and Suicide Prevention Act This bill authorizes competitive grants to enhance services for school-aged youth with mental and behavioral health issues that can lead to poor academic performance, depression, and other negative outcomes. The Substance Abuse and Mental Health Services Administration (SAMHSA) may award the grants to state or local educational agencies or Indian tribes. SAMHSA must ensure geographic representation, including with respect to rural areas, in the distribution of grant funds.
United States · United States Congress · 10 February 2022
Opioid Treatment Access Act of 2022 This bill expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs. Specifically, the Department of Health and Human Services (HHS) must issue regulations to further increase patients' access to unsupervised use or handling of drugs for treatment. The Substance Abuse and Mental Health Services Administration (SAMHSA) must study the effects of these revisions, and HHS must, as appropriate, promulgate additional regulations based on the study's findings. SAMHSA must also study the impact of certain exemptions from certification requirements for opioid treatment programs that were granted as part of COVID-19 response efforts, including any additional costs or savings that resulted from the exemptions. The bill also (1) allows specified types of health care providers to prescribe (subject to certain requirements) methadone that is dispensed through pharmacies for a patient's unsupervised use, and (2) provides statutory authority for a regulation that allows registered opioid treatment programs to operate mobile medication units without separately registering the unit.
United States · United States Congress · 9 February 2022
Stop Unfair Medicaid Recoveries Act of 2022 This bill prohibits state Medicaid programs from using estate recovery to recoup the costs of benefits. States must withdraw property liens within 90 days of the bill's enactment.
United States · United States Congress · 9 February 2022
Safeguarding Women's and Children's Health Act of 2022 This bill imposes reporting requirements relating to abortion drugs. The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug. The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events. The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.
United States · United States Congress · 9 February 2022
Independent VA Audit Act This bill requires the Department of Veterans Affairs (VA) to seek to enter into an agreement with a nongovernmental entity to audit the VA's health care system, including with respect to the timeliness of available appointments for veterans to receive hospital care and medical services. The VA must submit the audit to Congress not later than December 31, 2023.